Camp4 Therapeutics Corporation · NASDAQ:CAMP

Enavate Sciences Gp, LLC reported a 8.10% stake in Camp4 Therapeutics Corporation (Schedule 13D/A)

Event Sep 11, 2025 · Filed Sep 15, 2025

Enavate Sciences Gp, LLC reported a 8.10% stake in Camp4 Therapeutics Corporation, 3,785,802 shares, with active intent on Sep 11, 2025. Filed Sep 15, 2025 (Schedule 13D/A).

Stake
8.10%
Shares
3,785,802
Intent
Active
What changed
Stake changed
Filed together
2 holders

The filing in full

HolderStakeShares
Enavate Sciences GP, LLC8.10%3,785,802
Everest Aggregator, LP8.10%3,785,802

Source

View original at SEC

Related